This data indicated that MIP-1β could also recruit MDSCs and CD68+CD163+M2-like macrophages of NSCLC patients during radiotherapy, thereby playing a vital role in evaluating the inflammation environment of radiation therapy. The gene discussed is CD68; the disease is non-small cell lung carcinoma.